Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Andapharm, LLC
WARNING LETTER
•Andapharm, LLC•October 10, 2014

Andapharm, LLC – FDA Warning Letter, Oct 10, 2014

Record Details

The FDA issued a Warning Letter to Andapharm, LLC for non-compliance with the Generic Drug User Fee Amendments of 2012 (GDUFA). The facility failed to pay the required annual facility fees for fiscal years 2013 and 2014, despite self-identifying. Under GDUFA (21 U.S.C. §§ 379j-41 to 379j-42), facilities manufacturing generic drug APIs or finished dosage forms must pay annual fees. As a result of the unpaid fees, all drugs and APIs manufactured by Andapharm, LLC are considered misbranded, violating 21 U.S.C. §§ 352(aa) and 379j-42(g)(4)(A)(iii). Shipping these misbranded products in interstate commerce, including importation, is a violation of federal law (21 U.S.C. § 331(a)). The facility has been placed on a publicly available GDUFA facility arrears list. Andapharm is required to immediately pay the outstanding 2013 and 2014 fees and respond within 15 working days with corrective actions. Failure to comply could lead to regulatory actions such as seizure, injunction, import alerts, and non-receipt of future generic drug submissions. The firm was also advised to contact the Drug Shortages Program if considering production reductions.

Company
Andapharm, LLC
Inspection date
October 10, 2014
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Michael M. Levy
View Company Profile

ID · 782ad040-ec55-4999-a423-0e376ae0939d

Violation Codes10
21 U.S.C. 331(a)21 U.S.C. 379j-4121 U.S.C. 379j-4221 U.S.C. 379j-41(5)(A)(i)21 U.S.C. 379j-42(f)21 U.S.C. 379j-42(a)(4)21 U.S.C. 379j-42(l)21 U.S.C. 352(aa)21 U.S.C. 379j-42(g)(4)(A)(iii)21 U.S.C. 332

Full citation text and observation details available on the Dashboard.

Other documents for Andapharm, LLC
  • WARNING_LETTER - 2018-07-18July 18, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Andapharm, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.